论文部分内容阅读
应用低剂量 IL—2和低剂量放/化疗综合治疗16例晚期癌症。CR 者占37.5%,PR 者占56.3%,总有效率(CR+PR)93.8%,1年生存率87.5%。表明此方案是治疗晚期癌症的一种较有效的手段。
Low-dose IL-2 and low-dose radiotherapy/chemotherapy were used to treat 16 cases of advanced cancer. CR accounted for 37.5%, PR accounted for 56.3%, total effective rate (CR+PR) was 93.8%, and 1-year survival rate was 87.5%. Show that this program is a more effective means of treatment of advanced cancer.